Ina Weiner

Ina Weiner's AcademicInfluence.com Rankings

Ina Weiner

Psychology

#3735

World Rank

#4192

Historical Rank

psychology Degrees

Download Badge

Psychology

Ina Weiner's Degrees

PhD Psychology Tel Aviv University

Why Is Ina Weiner Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ina Weiner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum (2000) (622)
Immune Activation During Pregnancy in Rats Leads to a PostPubertal Emergence of Disrupted Latent Inhibition, Dopaminergic Hyperfunction, and Altered Limbic Morphology in the Offspring: A Novel Neurodevelopmental Model of Schizophrenia (2003) (456)
The organization of the basal ganglia-thalamocortical circuits: Open interconnected rather than closed segregated (1994) (428)
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment (2003) (378)
Neural substrates of latent inhibition: the switching model. (1990) (374)
Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. (2005) (345)
Disruption of latent inhibition by acute administration of low doses of amphetamine (1988) (294)
The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry (1997) (275)
The switching model of latent inhibition: an update of neural substrates (1997) (238)
Chronic amphetamine and latent inhibition (1981) (192)
The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia (1995) (179)
Conditioned Attention Theory1 (1981) (179)
The latent inhibition model of schizophrenic attention disorder Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli (1991) (178)
Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia (2005) (152)
Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity (1996) (150)
The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat (1998) (149)
Electrolytic lesions of the medial prefrontal cortex in rats disrupt performance on an analog of the Wisconsin Card Sorting Test, but do not disrupt latent inhibition: implications for animal models of schizophrenia (1997) (149)
Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia. (2011) (144)
Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats (1987) (141)
Clozapine Administration in Adolescence Prevents Postpubertal Emergence of Brain Structural Pathology in an Animal Model of Schizophrenia (2009) (136)
Abnormal Trajectories of Neurodevelopment and Behavior Following In Utero Insult in the Rat (2011) (134)
From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. (1992) (124)
Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation (2003) (121)
Using the pharmacology of latent inhibition to model domains of pathology in schizophrenia and their treatment (2009) (112)
The effects of early handling on latent inhibition in male and female rats. (1985) (110)
Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats (2004) (109)
Tracing the development of psychosis and its prevention: What can be learned from animal models (2012) (107)
Latent inhibition and schizophrenia (1987) (106)
Rat Strain Differences in Open-Field Behavior and the Locomotor Stimulating and Rewarding Effects of Amphetamine (1998) (100)
The effects of smoking on acoustic prepulse inhibition in healthy men and women (1998) (96)
The latent inhibition model of schizophrenia: Further validation using the atypical neuroleptic, clozapine (1996) (91)
Early handling and latent inhibition in the conditioned suppression paradigm. (1987) (89)
Differential Effects of Prenatal Stress in Two Inbred Strains of Rats (1998) (89)
Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats (2012) (88)
Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity (2000) (87)
Facilitation of latent inhibition by haloperidol in rats (2004) (81)
Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol (2003) (79)
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat (2008) (79)
Latent inhibition : cognition, neuroscience, and applications to schizophrenia (2010) (79)
The effects of pre- and postweaning rearing conditions on latent inhibition and partial reinforcement extinction effect in male rats. (1990) (76)
Effects of electrolytic lesions of the medial prefrontal cortex or its subfields on 4-arm baited, 8-arm radial maze, two-way active avoidance and conditioned fear tasks in the rat (1997) (75)
Isolated Mitochondria Transfer Improves Neuronal Differentiation of Schizophrenia-Derived Induced Pluripotent Stem Cells and Rescues Deficits in a Rat Model of the Disorder (2018) (74)
The Latent Inhibition Model Dissociates between Clozapine, Haloperidol, and Ritanserin (2000) (72)
The effects of electrolytic lesion to the shell subterritory of the nucleus accumbens on delayed non-matching-to-sample and four-arm baited eight-arm radial-maze tasks. (1997) (67)
Contemporary Issues in Modeling Psychopathology (2000) (65)
Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: Implications for a possible antipsychotic action of ondansetron (1994) (63)
Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion (1999) (63)
Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course (2015) (63)
Latent inhibition is disrupted by nucleus accumbens shell lesion but is abnormally persistent following entire nucleus accumbens lesion: The neural site controlling the expression and disruption of the stimulus preexposure effect (2005) (61)
Haloperidol- and Clozapine-Induced Enhancement of Latent Inhibition with Extended Conditioning: Implications for the Mechanism of Action of Neuroleptic Drugs (1997) (60)
The abolition of the partial reinforcement extinction effect (PREE) by amphetamine: Disruption of control by nonreinforcement (1987) (57)
Neonatal Nonhandling and In Utero Prenatal Stress Reduce the Density of NADPH-Diaphorase-Reactive Neurons in the Fascia Dentata and Ammon’s Horn of Rats (1997) (56)
Simultaneous brightness discrimination and reversal: The effects of amphetamine administration in the two stages (1986) (55)
Mapping Brain Regions in Which Deep Brain Stimulation Affects Schizophrenia-Like Behavior in Two Rat Models of Schizophrenia (2013) (55)
Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration (2001) (53)
Pro-Cognitive and Antipsychotic Efficacy of the α7 Nicotinic Partial Agonist SSR180711 in Pharmacological and Neurodevelopmental Latent Inhibition Models of Schizophrenia (2009) (52)
Amphetamine and the overtraining reversal effect (1986) (51)
The effects of hippocampal and fimbria-fornix lesions on prepulse inhibition. (1999) (50)
Lesions to the basolateral amygdala and the orbitofrontal cortex but not to the medial prefrontal cortex produce an abnormally persistent latent inhibition in rats (2004) (49)
Distribution of Latent Inhibition By Interupting the Subicular Input To Nucleus Accumbens and Its Antagonism By Haloperidol (1992) (48)
AVE1625, a cannabinoid CB1 receptor antagonist, as a co-treatment with antipsychotics for schizophrenia: improvement in cognitive function and reduction of antipsychotic-side effects in rodents (2011) (47)
Phencyclidine does not disrupt latent inhibition in rats: Implications for animal models of schizophrenia (1992) (47)
Associative and nonassociative processes in latent inhibition: an elaboration of the Pearce–Hall model (2010) (46)
Deep brain stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia (2016) (45)
Amphetamine and the multitrial Partial Reinforcement Extinction Effect (PREE) in an operant chamber: Procedural modifications that lead to an attenuation of the PREE (1992) (45)
A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine (2003) (44)
SAR110894, a potent histamine H3-receptor antagonist, displays procognitive effects in rodents (2012) (44)
Latent inhibition is unaffected by direct dopamine agonists (1991) (43)
Scopolamine Induces Disruption of Latent Inhibition which is Prevented by Antipsychotic Drugs and an Acetylcholinesterase Inhibitor (2007) (43)
Maternal immune activation produces neonatal excitability defects in offspring hippocampal neurons from pregnant rats treated with poly I:C (2016) (42)
The effects of amphetamine on a multitrial partial reinforcement extinction effect (PREE) in an operant chamber (1989) (42)
Fimbria-fornix cut affects spontaneous activity, two-way avoidance and delayed non matching to sample, but not latent inhibition (1998) (40)
Basolateral amygdala lesions do not disrupt latent inhibition (1995) (40)
Abnormally persistent latent inhibition induced by lesions to the nucleus accumbens core, basolateral amygdala and orbitofrontal cortex is reversed by clozapine but not by haloperidol. (2006) (40)
Putative cognitive enhancers in preclinical models related to schizophrenia: The search for an elusive target (2011) (39)
Abnormally persistent latent inhibition induced by MK801 is reversed by risperidone and by positive modulators of NMDA receptor function: differential efficacy depending on the stage of the task at which they are administered (2008) (39)
Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. (1999) (39)
Effects of smoking status and schizotypy on latent inhibition (1999) (39)
Amelioration of behavioral deficits in a rat model of Huntington's disease by an excitotoxic lesion to the globus pallidus (2004) (38)
Sex-Dependent Antipsychotic Capacity of 17β-Estradiol in the Latent Inhibition Model: A Typical Antipsychotic Drug in Both Sexes, Atypical Antipsychotic Drug in Males (2010) (38)
The M₁/M₄ preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia. (2011) (38)
Dopamine in Schizophrenia Dysfunctional Information Processing in Basal Ganglia — Thalamocortical Split Circuits (2002) (36)
Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia (2018) (36)
Clozapine-induced potentiation of latent inhibition is due to its action in the conditioning stage: implications for the mechanism of action of antipsychotic drugs. (1999) (36)
Disrupted and Undisruptable Latent Inhibition following Shell and Core Lesions (1999) (36)
Contrasting Effects of Increased and Decreased Dopamine Transmission on Latent Inhibition in Ovariectomized Rats and Their Modulation by 17β-Estradiol: An Animal Model of Menopausal Psychosis? (2010) (35)
Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling : implications for a neurodevelopmental animal model of schizophrenia (1998) (35)
An Animal Model of Attention Deficit (1991) (34)
Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease (1998) (34)
Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs. (2009) (33)
The effects of amphetamine on a multitrial partial reinforcement extinction effect (PREE) in a runway (1989) (31)
Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus (1997) (31)
Latent inhibition is spared by n-methyl-d-aspartate (nmda)-induced ventral hippocampal lesions, but is attenuated following local activation of the ventral hippocampus by intracerebral nmda infusion (2004) (29)
Screening of antipsychotic drugs in animal models (2000) (28)
The effects of the new antipsychotic, sertindole, on latent inhibition in rats (1994) (28)
Disruption and Potentiation of Latent Inhibition by Risperidone: The Latent Inhibition Model of Atypical Antipsychotic Action (2003) (28)
The Latent Inhibition Model of Schizophrenia (2000) (28)
Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone (2009) (27)
The effects of radiofrequency lesion or transection of the fimbria–fornix on latent inhibition in the rat (1999) (26)
Immune activation in lactating dams alters sucklings' brain cytokines and produces non-overlapping behavioral deficits in adult female and male offspring: A novel neurodevelopmental model of sex-specific psychopathology (2017) (25)
The effects of compound stimulus preexposure of two elements differing in salience on the acquisition of conditioned suppression (1982) (24)
Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats (1989) (23)
Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine (2004) (22)
Increased extracellular free-water in adult male rats following in utero exposure to maternal immune activation (2020) (22)
Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning. (1998) (22)
Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia (2003) (22)
Maturation- and sex-sensitive depression of hippocampal excitatory transmission in a rat schizophrenia model (2016) (21)
Reversal and nonreversal shifts under amphetamine (2004) (20)
Amphetamine-Induced Disruption of Latent Inhibition Is Not Reinforcer-Mediated (1997) (20)
The neuropathological contribution of prenatal inflammation to schizophrenia (2011) (19)
Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system (2004) (18)
Latent Inhibition: Issues in latent inhibition research and theory: an overview (2010) (18)
Basolateral amygdala lesions in the rat produce an abnormally persistent latent inhibition with weak preexposure but not with context shift (2005) (17)
Fluctuation of latent inhibition along the estrous cycle in the rat: Modeling the cyclicity of symptoms in schizophrenic women? (2008) (16)
The effects of amphetamine on blocking (1987) (16)
Amphetamine‐induced disruption of latent inhibition depends on the nature of the stimulus (1997) (15)
Differential Role of Muscarinic Transmission within the Entorhinal Cortex and Basolateral Amygdala in the Processing of Irrelevant Stimuli (2010) (14)
The effects of haloperidol on the partial reinforcement extinction effect (PREE): implications for neuroleptic drug action on reinforcement and nonreinforcement (2004) (14)
Latent inhibition is disrupted by acute and repeated administration of corticosterone. (1998) (14)
The abolition of the partial reinforcement extinction effect (PREE) by amphetamine (2004) (14)
A neuroleptic-like effect of ceronapril on latent inhibition (1992) (13)
The sigma ligand BMY‐14802 as a potential antipsychotic: evidence from the latent inhibition model in rats (1995) (12)
Effects of haloperidol on the multitrial partial reinforcement extinction effect (PREE): evidence for neuroleptic drug action on nonreinforcement but not on reinforcement (2005) (12)
The latent inhibition model of schizophrenic attention disorder and of antipsychotic drug action: comment on Dunn, Atwater and Kilts (Psychopharmacology, 1993, 112:315–323) (1994) (11)
Confounding of controllability in the triadic design for demonstrating learned helplessness. (1981) (11)
Dissociating scopolamine-induced disrupted and persistent latent inhibition: stage-dependent effects of glycine and physostigmine (2010) (9)
The effects of chronic administration of ceronapril on the partial reinforcement extinction effect and latent inhibition in rats (1994) (9)
Abnormally rapid reversal learning and reduced response to antipsychotic drugs following ovariectomy in female rats (2012) (9)
Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: A potential novel treatment in a rat model of Huntington's disease (2003) (8)
Resistance to Extinction and Punishment following Training with Shock and Non-Reinforcement: Failure to Obtain Cross-Tolerance (1987) (7)
Early perceptual loss in depression (2007) (6)
Editorial: Special issue on modeling schizophrenia (2009) (6)
Latent Inhibition: What the brain teaches us about latent inhibition (LI): the neural substrates of the expression and prevention of LI (2010) (6)
Strain differences in latent inhibition (1998) (6)
The accumbens–substantia nigra pathway, mismatch and amphetamine (1991) (6)
Generality of US preexposure effects: Effect of shock or food preexposure on water escape (1979) (5)
The effects of clonidine on the partial reinforcement extinction effect (PREE) (2004) (5)
Parahippocampal region–dopaminergic neuron relationships in latent inhibition (2010) (4)
Latent Inhibition: The pharmacology of latent inhibition and its relevance to schizophrenia (2010) (3)
Long-term functional consequences of quinolinic acid striatal lesions and their alteration following an addition of a globus pallidus lesion assessed using pharmacological magnetic resonance imaging (2005) (3)
Latent Inhibition: Summary and conclusions (2010) (3)
P.3.d.021 Physostigmine reverses MK-801-induced but not amphetamine-induced effects on latent inhibition: focus on cholinergic treatments in schizophrenia (2006) (3)
39th Annual European Brain and Behaviour Society Abstracts (2007) (2)
Maternal immune stimulation leads to cognitive deficits in the adult offspring which are alleviated by antipsychotic treatment: A novel neurodevelopmental model of schizophrenia in the rat (2001) (2)
The role of nucleus accumbens subterritories in latent inhibition (1997) (2)
Latent Inhibition (2001) (1)
P.2.002 The neural circuitry of persistent latent inhibition as a model of negative symptoms in schlophrenia (2003) (1)
P.2.07 Muscarinic transmission in the entorhinal cortex mediates inattention to irrelevant stimuli: relevance to schizophrenia (2008) (1)
Amphetamine does not affect the partial punishment effect (PPE) (2004) (1)
The effects of chronic corticosterone administration on amphetamine-induced activity, spatial learning and latent inhibition (LI) (1997) (1)
P.3.b.009 Loss of latent inhibition in ovariectomized female rats: possible link to the oestrogen hypothesis of schizophrenia (2006) (1)
Abstracts of the 15th Annual Meeting of the Israel Society for Neuroscience Eilat, Israel, December 3–5, 2006 (2006) (1)
P.1.c.035 Behavioral and pharmacological changes after neonatal nitric oxide inhibition: a model of negative symptoms (2007) (1)
Comprar Latent Inhibition | Robert Lubow | 9780521517331 | Cambridge University Press (2010) (1)
The Effects of Early Handling on the Partial Reinforcement Extinction Effect and the Partial Punishment Effect in Male and Female Rats (1987) (1)
Post-pubertal emergence of schizophrenia-like abnormalities following prenatal immune activation in rats (2002) (0)
The split circuit scheme: An account for the symptomatology of huntington's disease (1997) (0)
Electrolytic lesion of the globus pallidus reduces the neurodegenerative effects of quinolinic acid lesion of the striatum in the rat (1997) (0)
40.4 EFFECTIVE EARLY INTERVENTION WITH RISPERIDONE OR CLOZAPINE IN FEMALE RATS PRENATALLY EXPOSED TO POLY-I:C: MUST TAKE PLACE BEFORE THE EMERGENCE OF BEHAVIORAL ABNORMALITIES AND REQUIRES NORMALIZATION OF STRUCTURAL DEFICITS (2019) (0)
Pre-pubertal clozapine administration prevents post-pubertal emergence of brain structural pathology in an animal model of schizophrenia (2013) (0)
P.3.d.005 The antimuscarinic latent inhibition model: modeling neuroleptic-resistant cognitive impairments in schizophrenia (2007) (0)
The latent inhibition model discriminates between typical and atypical antipsychotics (1999) (0)
P.2.26 Perseverative behavior after neonatal nitric oxide blockade is alleviated following enhanced NMDA but not DA function (2007) (0)
Poster #T75 PRENATAL EXPOSURE TO MATERNAL IMMUNE STIMULATION LEADS TO CHANGES IN MYELIN PROTEINS IN THE ADULT RAT PREFRONTAL CORTEX WHICH CAN BE PREVENTED BY RISPERIDONE IN ADOLESENCE (2014) (0)
P.2.14 Dysfunctional and therapeutic effects of nitric oxide inhibition in a neurodevelopmental model of negative symptoms (2008) (0)
P.3.b.008 N-acetylcysteine prevents prenatal poly I:C-induced disruption of latent inhibition and increase in tyrosine hydroxylase (2007) (0)
Individual differences in latent inhibition in rats (1997) (0)
P.3.a.011 Lactational immune activation model: from trans-diagnostic risk to trans-diagnostic prevention (2017) (0)
T194. BRAIN STRUCTURAL AND BEHAVIORAL ABNORMALITIES FOLLOWING PRENATAL EXPOSURE TO MATERNAL INFLAMMATION ARE PREVENTED BY EARLY BUT NOT LATE INTERVENTION (2018) (0)
Abstracts of the 16th Annual Meeting of The Israel Society for Neuroscience Eilat, Israel, November 25–27, 2007 (2008) (0)
The relative control by S+ and S- in discrimination learning under D-amphetamine (1987) (0)
Time-Dependent Effects of Risperidone on Hippocampal Neurogenesis in the Poly I:C Model of Schizophrenia (2010) (0)
T113. ULTRA-LOW DOSE OF RISPERIDONE GIVEN IN ADOLESCENCE PREVENTS STRUCTURAL BRAIN AND BEHAVIORAL ABNORMALITIES INDUCED BY GESTATIONAL OR LACTATIONAL EXPOSURE TO MATERNAL IMMUNE ACTIVATION (2019) (0)
The atypical neuroleptic clozapine facilitates latent inhibition (1997) (0)
PREVENTION OF POST-PUBERTAL SCHIZOPHRENIA-LIKE BEHAVIOR AND NEUROPATHOLOGY DURING THE PRODROME IN THE MATERNAL IMMUNE ACTIVATION MODEL (2008) (0)
40. EARLY INTERVENTION IS EFFECTIVE IN HALTING DEVELOPMENTAL NEUROPATHOLOGY AND BEHAVIORAL DEFICITS: LESSONS FROM MODEL RODENTS (2019) (0)
Latent Inhibition: Preface (2010) (0)
The reversal of an attentional deficit in nonhandled male rats — The possible involvement of the dopaminergic system (1987) (0)
Total nucleus acumbens lesion but not a restricted shell lesion lead to impaired performance and perseveration in a 4-baited-16-hole-board (1997) (0)
15-5 The open interconnected scheme of basal ganglia-thalamocortical circuitry and psycho/neuropathology (1997) (0)
Models of Psychoses: Which One, When, and Why? (2000) (0)
CLOZAPINE‐INDUCED POTENTIATION OF LATENT INHIBITION IS DUETOTHE ACTION OFTHE DRUG IN THE CONDITIONING STAGE (1998) (0)
P.0844 Long-term effect of maternal immune activation in nursing dams on neurobiological, brain volume and behavioral alterations in the offspring (2021) (0)
Electrolytic lesion of globus pallidus ameliorates the behavioral effects of quinolinic acid lesion of the striatum: A potential novel treatment in a rat model of Huntington's disease (1997) (0)
Amphetamine and reversal learning (1986) (0)
O-18-2 Clozapine in the latent inhibition (LI) model: Atypical or a typical neuroleptic? (1996) (0)
P.3.b.001 Restoration of latent inhibition in ovariectomized rats by neuroleptics requires estrogen (2007) (0)
P.2.02 Differential sensitivity to dopaminergic manipulations following ovariectomy: an animal model of menopausal psychosis (2008) (0)
Erratum to “Long-term functional consequences of quinolinic acid striatal lesions and their alteration following an addition of a globus pallidus lesion assessed using pharmacological magnetic resonance imaging” [Exp. Neurol. 196 (2005) 244–253] (2006) (0)
40.4 LOW-DOSE RISPERIDONE TREATMENT IN ADOLESCENCE PREVENTS THE DEVELOPMENT OF NEUROINFLAMMATION IN THE MATERNAL IMMUNE ACTIVATION MODEL (2018) (0)
Facilitation of discrimination transfers under amphetamine: the relative control by S+ and S− and general transfer effects (2004) (0)
Neuronal and Behavioral Abnormalities in Schizophrenia Derived Cells and Animal Model are Amended by Mitochondria Transplantation (2020) (0)
EP 18. Deep Brain Stimulation improves behavior and modulates neural circuits in a rodent model of schizophrenia (2016) (0)
The Latent Inhibition Model Further Validation Using the Clozapine of Schizophrenia : Atypical Neuroleptic (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ina Weiner?

Ina Weiner is affiliated with the following schools:

Tel Aviv University